The relationship between lncH19 and TP53 is controversial in the literature since some papers sustain a negative control of TP53 by H19 (Yang et al., 2012; Li et al., 2020; Gan et al., 2022), while others support that lncH19 may activate the tumor suppressor. The gene discussed is H19; the disease is neoplasm.